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Cytochrome P450 monooxygenases
(P450s) are a supergene family of enzymes
involved in the biotransformation ofa wide
range of both endogenous and exogenous
compounds. P450s play important roles in
the metabolism of many drugs and in the
activation ofa variety ofchemical toxicants
and carcinogens in both humans and ani-
mals (1,2). High levels ofP450s exist prin-
cipally in the liver (1), and studies using
immunohistochemical techniques (3-6)
and in situ hybridization (7) have demon-
strated differences in the regional distribu-
tion and region-specific induction ofseveral
P450s within the liver.
Constitutive activities and inducibility
ofdifferent P450 isozymes are important in
dictating species and individual differences
in susceptibility to toxicants. The ability to
assess gene expression and resulting enzyme
activity without tissue disruption on an
individual cell basis would further our abili-
ty to identifylinkages between P450 expres-
sion and the zonal distribution of hepatic
lesions caused bydifferent toxicants.
Recently, we reported on the use of
alkoxyresorufin homologues in combina-
tion with noninvasive scanning laser cytom-
etry as a method for directly determining
CYPlAl functional activity in hepatoma
cell lines (8). In the present study, we used
precision-cut, viable rat liver slices and
confocal laser cytometry to determine the
regional activities ofP450 isozymes insitu.
A slice perfusion chamber that mounts
on the cytometer stage was developed to
allow for successive measurement of
region-specific, P450-dependent 0-dealky-
lation of7-ethoxy-, 7-pentoxy-, and 7-ben-
zyloxyresorufin (EROD, PROD, and
BROD activity, respectively) in the same
liver slice. EROD activity in rat liver has
been shown to be specific to CYPIA
isozymes and is inducible by ,-naph-
thoflavone (,NF) and other polycyclic aro-
matic hydrocarbon-type inducing agents
(8,9). BROD and PROD activities have
been shown to be specific to CYP2B and
CYP3Aisozymes and are inducible byphe-
nobarbital (9,10). The perfusion system
ensures a constant concentration of sub-
strate and limits the extracellular accumu-
lation ofthe fluorescent product, resorufin
(9). In addition, the slice perfusion cham-
ber allows for residual substrate and prod-
uct to be washed away between successive
perfusion assays.
Materials and Methods
Chemicals. Earle's balanced salt solution
(EBSS) and Williams' E medium were
purchased from Gibco BRL (Grand Island,
New York). fiNF, factor II- and factor VII-
deficient rat plasma, rat thrombin, and
dicumarol were purchased from Sigma (St.
Louis, Missouri). 7-Ethoxy-, 7-pentoxy-,
and 7-benzyoloxyresorufin (ER, PR, and
BR, respectively) were purchased from
Boehringer Mannheim Corp. (Indianapolis,
Indiana), and resorufin was purchased from
Aldrich Chemical Co. (Milwaukee,
Wisconsin).
Animals and slicepreparation. Adult,
male Sprague-Dawley rats (150-200 g)
were purchased from Simenson Labs
(Gilroy, California) and were fed Wayne
Lablox and given water ad libitum. PNF-
treated rats were administered 65 mg/kg
body weight ,3NF in corn oil by intraperi-
toneal injection for 2 consecutive days
before sacrifice. Control rats were untreat-
ed. The perfusion technique and methods
for measurement of alkoxyresorufin 0-
dealkylase activities by scanning confocal
laser cytometry were developed during a
number of preliminary experiments.
Immunocytochemical, microsomal, and
dynamic organ culture (DOC) data were
obtained from the caudate lobes of a con-
trol and a ,NF-treated rat. Fluorescence
images and slice perfusion data were
obtained from the caudate lobes ofseparate
control and ,NF-treated rats.
Precision-cut, viable liver slices used in
laser cytometry experiments and in DOC
experiments were prepared as described by
Krumdieck et al. (11) using the Krumdieck
tissue slicer (K & F Research Co.,
Birmingham, Alabama). Briefly, animals
were killed by ether anesthetization/cervical
dislocation. Livers were excised and immedi-
ately placed in Williams' E medium con-
taining 10 mM HEPES (pH 7.4; referred to
as WEM from this point). An 8-mm metal
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biopsy corerwas used to prepare tissue cores
from the liver lobes. Cores were then placed
in the Krumdieck slicer while submerged in
WEM. Optimal slice thickness was previ-
ously shown to be 250 pim (11). The first
and last slices containing the liver capsule
were discarded. Liver slices were then
placed in DOC vials (2 slices/vial) contain-
ing 2 ml ofWEM as described by Smith et
al. (12). Slices were allowed to preincubate
for at least 2 hr before use in subsequent
perfusion assays or DOC EROD assays.
Slice perfusion. The slice perfusion
apparatus shown in Figure 1 was used to
successively measure region-specific
EROD, PROD, and BROD activities in
precision-cut liver slices. Aplasma clot sim-
ilar to that described by Gahwiler (13) was
formed by evenly distributing 25 pl of
reconstituted rat plasma (50 mg/ml PBS,
pH 7.4) on a 22-mm square glass cover
slip. We then added 10 p1 ofreconstituted
thrombin (117 U/ml in 0.15 M NaCl and
0.05 M sodium citrate, pH 6.5) to the cen-
ter of the plasma-coated cover slip. The
liver slice was then placed on the rapidly
formed plasma clot. A cover glass perfusion
chamber similar to that described by
Forscher et al. (14) was formed by sus-
pending the cover slip holding the liver
slice over a microscope slide on two 720-
pm thick plastic spacers. The spacers and
cover slip were held in place by coating
spacers with a thin film ofsilicone grease.
The microscope slide portion of the
perfusion chamber was fixed to the
cytometer stage by a custom-designed stage
mount. The mount positioned the slide
over the microscope objective and held
reagent supply and vacuum lines in posi-
tion. Reagent was supplied via 0.58-mm
ID polyethylene tubing attached to a 25-
ml reservoir positioned approximately 30
cm above the perfusion chamber. A trian-
gular piece of filter paper attached to the
vacuum line was positioned on the outlet
side ofthe chamber, as shown in Figure 1,
to wick away reagent and provide for a
laminar flow ofreagent through the cham-
ber. Vacuum and reservoir height were
adjusted to establish a flow rate of 0.5
ml/min. Slice perfusion experiments were
carried out at room temperature.
EBSS (phenol-red-free, supplemented
with 10 mM HEPES, 5 mM MgCl2 and
2.5 mM CaCI2, pH 7.5), gassed with 95%
02/5% CO2 and containing 25 pM
dicumarol, was used as the perfusion
buffer. Dicumarol is a specific inhibitor of
quinone oxidoreductase (DT-diaphorase)
(15), a cytosolic enzyme involved in the
reduction of resorufin to a nonfluorescent
product. Dicumarol is therefore required in
reaction buffers to measure maximum
Figure 1. Liver slice perfusion chamber.
alkoxyresorufin O-dealkylase activities in
hepatic subcellular fractions and hepatocyte
homogenates (16). We used 25 pM
dicumarol in our assays with liver slices, as
this concentration was previously found to
be optimal for measuring CYPlAl func-
tional activity in hepatoma cell lines by
scanning laser cytometry (8). Sulfate anion
was omitted from the reaction buffer to
minimize conjugation via sulfation (17), as
previously described (8).
We determined region-specific EROD,
BROD, and PROD activities by adding
the appropriate alkoxyresorufin substrate to
the perfusion buffer to a final concentra-
tion of 5 piM. EBSS without substrate was
used to remove residual substrate and prod-
uct between successive perfusions. Slices
were washed with EBSS until fluorescence
returned to baseline levels and was moni-
tored by continuously scanning the liver
slice.
Laser cytometry. Alkoxyresorufin 0-
dealkylase activity was assessed directly in
liver slices using an ACAS (adherent cell
analysis and sorting) Ultima Laser
Cytometer (Meridian Instruments,
Okemos, Michigan) equipped with an
argon ion laser and image analysis software.
Initial focusing was carried out by examin-
ing the slice with normal transmitted light
using a lOx objective. The same objective
was used for laser illumination of the slice
in confocal mode (pinhole setting of 100
pm). Maximum fluorescence response
occurred within the first two to three cell
layers from the surface of the slice and
could be optimized by scanning in the Z.
direction upon addition of substrate.
Fluorescence due to resorufin formation
was monitored using an excitation wave-
length of 514 nm and an emission wave-
length of >570 nm (using a long-pass
dichroic filter). The photomultiplier tube
voltage was held constant and data were
collected using the kinetics software pack-
age supplied with the instrument. Data
were analyzed on a DASY9000 workstation
(Meridian Instruments). EROD, BROD,
and PROD activities were measured as
increases in fluorescence intensity (arbitrary
scale) within user-defined polygon regions
of the liver slice exhibiting maximum
EROD activity. Representative fluorescence
pseudocolor images were saved as tagged
image file format (TIFF) files and imported
into a MacIntosh IIci personal computer.
These images were then printed using
PowerPoint software (Microsoft Corp.,
Redmond, Washington) and a Tektronix
Phaser II SDX dye sublimation printer
(Tektronix Corp., Beaverton, Oregon).
Environmental Health Perspectives * Volume 104, Number5, May 1996 537Articles - Heinonen et al.
In vitro assays. We measured EROD
activity in liver slices isolated from control
and ,NF-treated rats in DOC as follows.
Slices were preincubated for 2 hr in WEM
as described above. Slices were then rinsed
with EBSS, then incubated in 2 ml EBSS
containing 5 pM ethoxyresorufin (ER) and
25 pM dicumarol. After the specified incu-
bation time, the concentration of fluores-
cent resorufin product in the culture medi-
um was determined by fluorescence spec-
trometry. We determined resorufin concen-
trations by comparing fluorescence intensity
with a standard curve prepared from
resorufin standards. All fluorescence mea-
surements were made on a Perkin-Elmer
LS-50 Luminescence Spectrofluorometer
(Beaconsfield, UK) using an excitation
wavelength of 530 nm and an emission
wavelength of580 nm.
Liver microsome samples were prepared
by standard procedures. Microsomal pro-
tein concentrations were determined by the
bicinchoninic acid method described by
Smith et al. (18). Microsomal (alkoxyre-
sorufin-O-dealkylase activity assays were
performed essentially as described by Burke
and Mayer (19) and Lubet et al. (20).
Microsomes were allowed to preincubate
for 2 min in 2 ml of 100 mM Tris-HCL
(pH 7.5) containing 5 mM MgCl2 and 5
pM alkoxyresorufin substrate. Reactions
were initiated by adding 10 pl of 100 mM
NADPH (final concentration of 500 pM
NADPH) and were carried out at 370C.
Maximum EROD activities were obtained
using 148 pig of control microsomal pro-
tein and 14 pg ofPNF-treated microsomal
protein. Maximum BROD and PROD
activities were obtained using 148 pg of
control microsomal protein and 140 pg of
3NF-treated microsomal protein. We
monitored reaction kinetics on the lumi-
nescence spectrofluorometer described
above using the kinetics software package
supplied with the instrument.
Slice viability. We used control rat liver
slices to determine the effect of culture
method (DOC versus perfusion) and the
effect of treatment (EBSS control versus
EBSS containing 5 pM ER and 25 pM
dicumarol) on slice viability. Intracellular
K+ concentrations were measured in three
slices before preincubation began (0 hr), in
three slices that had been preincubated 2 hr
in WEM, and in three slices from each of
the culture and treatment groups at two
time points (30 and 60 min). Intracellular
K+ determinations were performed as
described by Fisher et al. (21).
Immunocytochemistry. Immunocyto-
chemical staining of rat liver sections was
performed by the method of Farin et al.
(22) using a Vectastain ABC kit (Vector
Laboratories, Burlingame, California).
Briefly, acetone-fixed, 5-pm thick, paraffin
sections of control and PNF-treated rat
liver on poly-L-lysine coated slides were
deparaffinized and rehydrated. Tissue sec-
tions were sequentially exposed to normal
goat serum for 30 min to decrease nonspe-
cific binding, previously prepared anti-
CYPlAl primary antibody for 90 min,
biotinylated goat-anti-rabbit IgG sec-
ondary antibody for 60 min, avidin-conju-
gated horseradish peroxidase complex for
60 min, 3,3'-diaminobenzidine in Tris-
saline containing H202 for 10 min, and
1% osmium tetroxide for 2 min. Between
each of these components, the tissue sec-
tions were washed extensively with phos-
phate-buffered saline. The tissue sections
were counterstained with 2% methyl green,
and dehydrated, and cover slips were
placed on top of the tissue sections with a
drop ofmounting fluid. We confirmed the
specificity of the CYPlAI antibody by
Western blot analysis ofcontrol and ,BNF-
treated HepG2 cells and rat liver (23). The
antibody bound only to a single microso-
mal protein isolated from PNF-treated
HepG2 cells, indicating that the antibody
does not cross-react with CYP1A2 [see
Farin et al. (22) for details of antibody
preparation and specificity].
Statistical analysis. Intracellular K+
concentrations for preincubated slices and
slices that were perfused or incubated by
DOC both with and without substrate at
30 and 60 min were compared by analysis
of variance. EROD, PROD, and BROD
activities measured by slice perfusion were
BNF Treated
II~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Control
Figure 2. Comparison of ethoxyresorufin-O-deethylase (EROD) activity in liver slices isolated from P-naph-
thoflavone (I3NF)-treated and control rats. Fluorescence images were acquired by confocal laser cytome-
try of liver slices perfused on the cytometer stage with 5 pM ethoxyresorufin (ER) as described in
Materials and Methods. Numbers in the upper left-hand corner of each frame represent the time course
of perfusion with ER in seconds. fNF-induced increases in CYPlAl-associated EROD activity are seen as
increases from violetto red as depicted on the fluorescence intensity scale bar shown on the right.
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compared by regression analysis. We used
the StatView statistics program (Brain-
Power Inc., Calabasas, California) for sta-
tistical analyses. Scheffe's F-test was used to
establish significant differences.
Results
Liver slice intracellular K+ concentrations
increased from 35.4 ± 5.0 pmol K+/g liver
(mean ± SD) to 56.6 ± 5.0 pmol K+/g liver
during the 2-hr preincubation period (data
not shown). Recovery of intracellular K+
during the preincubation period is charac-
teristic of viable liver slices (12).
Preincubated slices that were then incubat-
ed with or without ER for 30 and 60 min
by DOC at 370C maintained 94-103% of
the intracellular K+ measured in preincu-
bated slices. Intracellular K+ concentrations
in liver slices perfused at room temperature
appeared to decrease after a 30-min perfu-
sion (42.9 ± 7.8 and 42.4 ± 8.1 in control
and ER-treated slices, respectively), then
increase after a 60-min perfusion (50.0 ±
5.8 and 44.9 ± 4.1 in control and EROD-
treated slices, respectively). However, when
the mean intracellular K+ values for all
treatment groups (DOC versus perfusion
and EBSS control versus EBSS containing
5 pM ER and 25 pM dicumarol) and
Figure 3. Comparison of CYPlAl expression in liver sections isolated from (top) ,-naphthoflavone (BNF)-
treated and (bottom) control rats. Sections were subjected to immunocytochemical staining for CYPlAl as
described in Materials and Methods. PNF-induced increases in centrilobular expression of CYPlAl are
shown as dark-staining regions surrounding central veins in sections isolated from a pNF-treated rat. C,
central vein; P, portal vein. x40.
preincubated slices were compared, the dif-
ferences were not significant (p = 0.05).
The fluorescence images in Figure 2
were collected over a period ofminutes in
a typical experiment in which liver slices
isolated from control and PNF-treated rats
were perfused on the laser cytometer stage
with EBSS containing 5 pM ER. Areas of
increased fluorescence are due to the for-
mation of the fluorescent resorufin prod-
uct and are indicative of high EROD
activity. Whole-slice scans (data not
shown) revealed a heterogeneous pattern
of EROD activity, suggesting differential
induction of CYPIAl activity across
regions of the liver lobule. The time
elapsed during whole-slice scans made it
impractical for kinetic analyses of entire
slices, as fluorescence intensity increased
substantially during the time required to
stage-scan an entire slice (10 mm x 10
mm). Based on these kinetic considera-
tions, we chose to scan smaller fields (1
mm x 1 mm, requiring <30 sec/scan using
the fast-scanning mirror option on the
ACAS). These fields contained vascular
structures that appeared to be central
veins. These structures were visible bylight
microscopy and could be targeted during
initial focusing by manually positioning
the slice with the computer-controlled X,Y
stage. Areas of the slice where vascular
structures appeared to be circular, indicat-
ing theywere cut perpendicular to the slice
surface, were suitable fields for resolution
of the liver lobule. The size of the areas
scanned by confocal laser cytometry
roughly corresponds to the size of areas of
distinct zonal immunocytochemical stain-
ing ofCYPlAI shown in the photomicro-
graph of the liver section isolated from a
,BNF-pretreated rat (Fig. 3).
The fluorescence images in Figure 2
show areas ofintense fluorescence response
in a liver slice isolated from a fNF-treated
rat. The fluorescence level attained after
1275 sec of scanning in these areas is
approximately 600-800 fluorescence inten-
sity uniis (FIU), which is at least twofold
higher than that observed in less-intense
adjacent areas. Immunocytochemical data
showing high levels of CYPlAI in cen-
trilobular areas suggest that these images
depict high EROD activity in centrilobular
regions of the liver slice containing what
appear to be small central veins.
Perfusion ofcontrol rat liver slices with
ER resulted in a low fluorescence response
and reflects the relatively low EROD activi-
ty in uninduced rat liver (9,10,16,24). The
control rat liver section in Figure 3 reveals a
low, constitutive level of GYPlAl expres-
sion that is homogenous across the different
zonal regions of the liver. In contrast, the
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Figure 4. Sequential perfusion of liver slices isolated from ,B-naphthoflavone (PNF)-treated and control
rats with selected alkoxyresorufin substrates (5 pM). Slices were sequentially perfused on the laser
cytometer stage as described in Materials and Methods. ER , BR, and PR represent time point at which
ethoxy-, benzyloxy-, or pentoxyresorufin were added to the perfusion buffer, respectively. WO (washout)
represents time point at which respective substrate was removed from the perfusion buffer to wash out
residual resorufin product and return fluorescence to background levels before subsequent addition of
next substrate. Values representthe mean ± SD (dotted lines) of seven circular areas containing the max-
imum fluorescence response in ONF-treated liver slice. Control slice values were measured in one large,
circular area containing maximum fluorescence response.
,NF-treated rat liver section shows a
marked increase in CYPlAl expression, but
only in centrilobular regions.
To further substantiate the suggested
association between high centrilobular
expression of CYPlAl and the heteroge-
neous fluorescence response of the ,BNF-
treated rat liver slice perfused with ER, we
sequentially perfused liver slices from con-
trol and PNF-treated rats with ER, benzy-
loxyresorufin (BR), and pentoxyresorufin
(PR). Figure 4 demonstrates that the fluo-
rescence response of control rat liver slices
toward BR and PR is comparable to the
fluorescence response observed when con-
trol slices are perfused with ER. Increases
in fluorescence intensity were below the
limits of quantification (10 FIU/min) for
each of the three substrates in control
slices. These results indicate that rat liver
70
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Figure 5. Comparison of ethoxyresorufin-O-
deethylase (EROD) activity in liver slices isolated
from control and 3-naphthoflavone (ONF)-treated
rats by dynamic organ culture. Slices were incu-
bated with 5 pM ethoxyresorufin (ER) for 10, 20,
30, or 60 min as described in Materials and
Methods. EROD activity in liver slices isolated
from OiNF-treated rats was linearfor periods of up
to 60 min, and the rate of resorufin formation was
nearly60-fold higher in treated slicesthan in con-
trol slices.
slices have low, constitutive levels of
EROD, BROD, and PROD activity, as
has been shown previously in microsomes
from untreated rats (9,24).
In contrast to the equivalent response
of control slices toward ER, BR, and PR,
slices isolated from ,NF-treated rats show
a highly differentiated response toward
these three substrates. Figure 4 shows the
increase in fluorescence intensity of seven
defined areas containing cells and/or
groups of cells exhibiting maximum fluo-
rescence response. The relative maximum
fluorescence response of liver slices from
OiNF-treated rats toward ER is approxi-
mately 20-fold higher than the response
toward BR and PR. The maximum rate of
increase in fluorescence intensity over an
approximate 3-min time period for each of
the substrates in 3NF-treated slices was
307, 18.5, and 16.1 FIU/min for ER, BR,
and PR, respectively. These results indicate
that liver slices from ,NF-treated rats have
high EROD activity relative to BROD and
PROD activity and that EROD, BROD,
and PROD activities are at least 30-, 1.8-,
and 1.6-fold greater, respectively, in ,NF-
treatedslices than in control slices.
To ensure that the lack offluorescence
response of liver slices from ,NF-treated
rats perfused with BR and PR was not due
to possible depletion of cofactors resulting
from the preceding ER perfusion, we re-
perfused slices with ER following BR and
PR perfusion. The fluorescence response of
the liver slice during the second ER perfu-
sion approached the fluorescence response
observed during the initial perfusion (Fig.
4). The maximum rate of increase in fluo-
rescence intensity for the second ER perfu-
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Figure 6. Comparison of alkoxyresorufin-0-
dealkylase activities in liver microsomes isolated
from control and j-naphthoflavone (ONF)-treated
rats. Liver microsomes were prepared and incu-
bated as described in Materials and Methods
using a substrate concentration of 5 pM. Results
are expressed as means ± SD from triplicate
analyses.
sion was 193 FIU/min. Although this rep-
resents only 63% ofthe activity observed in
the initial ER perfusion (significant at p
<0.05), EROD activity measured during
the second ER perfusion is substantially
greater than the preceding BROD and
PROD activities. Taken together, these
findings suggest that only a small depletion
of cofactors that support 0-dealkylase
activity, such as NADPH, occurred during
the 60 min preceding the second ERperfu-
sion. The magnitude of the second ER
response indicates that the low BROD and
PROD activities shown in Figure 4 are
more likely due to low substrate-specific
isozyme expression rather than depletion of
cofactors.
Figure 5 shows the regression lines for
the amount of the fluorescent resorufin
product formed over time by liver slices
isolated from both control and ONF-treat-
ed rats incubated with 5 pM ER in DOC.
The correlation coefficient for the regres-
sion line that describes the rate ofresorufin
formation (EROD activity) in ,NF-
induced liver slices indicates a high degree
oflinearity (R2 = 0.949). This suggests, as
does the second ER perfusion in Figure 4,
that cofactors supporting 0-dealkylase
activity are adequately maintained in liver
slices from ONF-treated rats for periods of
at least 60 min. In addition, the slope of
the PINF-treated regression line is nearly
60-fold greater than the slope of the con-
trol regression line.
Figure 6 further demonstrates the selec-
tive induction of EROD activity by ONF,
as previously shown in whole-liver slice
perfusion experiments (Fig. 4). Micro-
somes isolated from ,BNF-treated rats had
greater than 20-fold higher EROD activity
than control rat liver microsomes. This is
consistent with previous studies that com-
pare microsomal EROD activity in control
and PNF-treated rats (9,24). It is interest-
ing to note, however, that the profile of 0-
dealkylase activities in microsomes does not
parallel the activity profile seen in whole-
liver slice perfusion experiments. The activ-
ity profile for liver slices isolated from
3NF-treated rats could be described as
EROD>>>BROD=PROD, whereas in
microsomes from PNF-treated rats, the
activity profile is EROD>BROD>>
PROD. These differences may be due to
the intact nature ofthe liver slice and may
reflect differences in isozyme kinetics as a
result of the more biologically relevant
cofactor and substrate concentrations
achieved in whole-cell systems.
Discussion
The fluorescence images in Figure 2 show
that perfusion of liver slices isolated from
3NF-treated rats with EBSS containing 5
pM ER results in an intense fluorescence
response localized to specific regions ofthe
liver lobule. Immunocytochemical staining
of liver sections isolated from control and
INF-treated rats (Fig. 3) demonstrates that
,BNF treatment results in centrilobular
induction of CYPlAl. Precision-cut liver
slices incubated with ER in DOC show
that slices isolated from ONF-treated rats
(Fig. 5) have nearly 60-fold higher EROD
activity than slices isolated from control
rats. In addition, analysis of a series of
alkoxyresorufin O-dealkylase activities in
precision-cut liver slices by confocal laser
cytometry (Fig. 4) shows that ONF treat-
ment results in increased EROD activity to
a much greater extent than either PROD
or BROD activity. A similar response is
observed in liver microsomes isolated from
control and jNF-treated rats (Fig. 6),
except that BROD activity was also
induced to a greater extent in microsomes
than in intact liver slices. Based on these
findings, we conclude that the fluorescence
images in Figure 2 accurately reflect high
levels of centrilobular EROD activity due
to region-specific induction ofCYPlAl by
iNF in the rat.
fNF and 3-methylcholanthrene (MC)
are prototypic inducing agents representa-
tive ofa broad range ofcompounds such as
polyaromatic hydrocarbons, coplanar poly-
chlorinated biphenyls, and 2,3,7,8-tetra-
chlorodibenzo-p-dioxin. Treatment with
these compounds results in increased
expression of the CYPIA gene family (2).
Baron et al. (25) showed by immunocyto-
chemical techniques that treatment ofmale
Holtzman rats with ,BNF (40 mg/kg) or
MC (25 mg/kg) results in increased expres-
sion of CYP1A isozymes that is nearly
homogeneous across the liver lobule. In
addition, the relative amounts and distribu-
tion of these isozymes are the same in the
right, median, left, and caudate lobes ofthe
liver (25). More recently, van Sliedregt and
van Bezooijen (6) found that the induc-
tion pattern in Brown Norway rats was
dependent on dose and that at low doses of
MC (2.5, 5, 7.5 and 10 mg/kg) the highest
expression levels were concentrated around
the central vein. Higher doses of MC (25
mg/kg) resulted in a homogeneous pattern
ofinduction.
Based on these findings and the com-
paratively high dose of fNF (65 mg/kg)
used in our experiments, we would expect
to see a homogenous pattern of CYPlAI
induction. However, we found that sec-
tions isolated from PNF-treated Sprague-
Dawley rats (Fig. 3) show very dark stain-
ing for CYPlAI in centrilobular areas only,
a pattern identical to that observed by van
Sliedregt et al. (6) at lowdoses ofMC.
Recent work using periportal and
perivenous hepatocytes isolated by zone-
restricted digitonin treatment during in situ
perfusion have demonstrated regional dif-
ferences in the constitutive expression and
inducibility ofa number ofP450s (4,26).
In addition, Buhler et al. (4) noted that the
inducible forms of P450 they studied
(2B1/2, 2E1, and 3A1) were generally
induced in hepatocytes of the same zonal
origin in which they were constitutively
expressed. These findings led them to sug-
gest that phenotypic differences exist
between centrilobular and periportal hepa-
tocytes with respect to factors that control
P450 expression, causing hepatocytes of
different zonal origins to respond different-
ly to exogenous and endogenous signals.
Comparative studies investigating the
phenobarbital responsiveness of rat hepatic
hyperplastic nodules (HHN) have provided
further evidence for phenotypic differences
between centrilobular and periportal hepa-
tocytes in factors that control P450 isozyme
expression. Phenobarbital induces CYP3A1
in centrilobular hepatocytes (23) and
CYP2B1/2 in centrilobular and midzonal
hepatocytes (23,27). Chen et al. (23, 28)
have demonstrated that HHNs induced by
the aflatoxin BI(AFB,) administration pro-
tocol (5) arise through clonal expansion of
centrilobular hepatocytes only. In contrast,
HHNs induced by the Solt-Farber induc-
tion protocol (5) are derived from cen-
triobular, midzonal, and periportal hepato-
cytes (28). When HHN-bearing rats were
administered phenobarbital, all AFB1-
induced HHNs expressed increased levels of
CYP3A1 and CYP2B1/2 (28). In contrast,
only a portion of Solt-Farber-induced
HHNs were shown to respond tO pheno-
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barbital as measured by increased expression
of these isozymes (23, 28). These findings
led Chen and Eaton (28) to hypothesize
that phenobarbital responsiveness is deter-
mined primarily by the zonal origin ofpre-
cursor hepatocytes and provide indirect evi-
dence for distinct, heritable phenotypic dif-
ferences between hepatocytes of different
zonal origin that control P450 expression.
At the present time, relatively little is
known about factors controlling region-spe-
cific constitutive and inducible P450
isozyme activity. Anundi et al. (26) and
Lindros et al. (29) have described linkages
between zone-specific P450 isozyme expres-
sion and zone-specific hepatic lesions. In
addition, the effects of P450 expression by
HHNs on tumor promotion and progres-
sion have been well documented (30).
These findings emphasize the importance of
developing in vitroassays that could be used
to colocalize functional P450 isozyme activ-
ity with factors governing P450 expression.
Sidhu et al. (8) have demonstrated the abil-
ity ofnoninvasive scanning laser cytometry
to measure CYPlAl functional activity in
hepatoma cell lines. More recently, this
same group demonstrated large individual
cell differences in the functional activity
and the immunoreactive protein content of
primary rat hepatocytes exposed to proto-
typic P450 inducers in vitro (8,31). The
ability of scanning laser cytometry to mea-
sure functional activity in a whole-cell sys-
tem led us to hypothesize that laser cytome-
try could be used to measure functional
P450 isozyme activity in viable precision-
cut liver slices and that, because the archi-
tecture of the liver lobule in liver slices
remains intact, marked differences in
regional activitycould be observed.
In conclusion, using a well-character-
ized induction protocol and P450 isozyme-
specific alkoxyresorufin substrates, we were
able to show that confocal laser cytometry
of precision-cut liver slices can be used to
assess P450 isozyme-specific induction in
intact liver tissue. More importantly, the
method allows for the analysis of region-
specific induction ofP450 activities, which
are difficult to determine by conventional
methods. These techniques should allow
for the accurate quantification of P450
enzyme activity in situ and, with subse-
quent analysis of the same slice after fixa-
tion and processing, the ability to correlate
specific P450 isozyme mRNA, specific
P450 isozyme protein content, or other
factors, with enzyme activity on an individ-
ual cell basis. These techniques should also
be amenable to examination ofsimilar phe-
nomena in other tissues such as lung and
kidney, where heterogeneity in cellular
P450 expression is also known to occur.
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Seventh
North American
ISSX( Meeting
October 20-24, 1996
The Seventh North American Meeting of the International Society for the Study of Xenobiotics
(ISSX) will take place in San Diego, California from October 20-24, 1996 at the historic Hotel del
Coronado.
The meeting will feature plenary lectures, symposia, poster sessions, continuing education, com-
mercial exhibits and presentations.
Scientific Program
Scientific Program will highlight these themes:
Enzymology of xenobiotic biotransformation
FMO and P450
Hydrolytic enzymes
Conjugating enzymes
Human drug metabolism and polymorphisms
In vitro test systems and methodologies
Enzyme induction
Drug development and safety evaluation
Environmental and agricultural chemicals
Cosmetic and food chemicals
Biotechnology products
Regulatory affairs
For more information:
ISSX
PO Box 3
Cabin John, MD 20818 USA
FAX: 301-983-5357
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